Literature DB >> 32940190

Regulation of microRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.

Sridhar Muthusami1, Ilangovan Ramachandran2, Sneha Krishnamoorthy1, Yuvaraj Sambandam3, Satish Ramalingam4, Lurdes Queimado5, Gautam Chaudhuri6, R Ileng Kumaran7.   

Abstract

The development of colorectal cancer (CRC) is a multi-stage process. The inflammation of the colon as in inflammatory bowel disease (IBD) such as ulcerative colitis (UC) or Crohn's disease (CD) is often regarded as the initial trigger for the development of CRC. Many cytokines such as tumor necrosis factor alpha (TNF-α) and several interleukins (ILs) are known to exert proinflammatory actions, and inflammation initiates or promotes tumorigenesis of various cancers, including CRC through differential regulation of microRNAs (miRNAs/miRs). miRNAs can be oncogenic miRNAs (oncomiRs) or anti-oncomiRs/tumor suppressor miRNAs, and they play key roles during colorectal carcinogenesis. However, the functions and molecular mechanisms of regulation of miRNAs involved in inflammation-associated CRC are still anecdotal and largely unknown. Consolidating the published results and offering perspective solutions to circumvent CRC, the current review is focused on the role of miRNAs and their regulation in the development of CRC. We have also discussed the model systems adapted by researchers to delineate the role of miRNAs in inflammation-associated CRC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Colorectal cancer (CRC); colitis-associated CRC (CAC); cytokines; inflammation; inflammationassociated CRC; inflammatory bowel disease (IBD); interleukin (IL); metastasis; microRNA (miRNA/miR); nuclear factorzzm321990(NF) kappa-light-chain-enhancer of activated B cells (NFκB); tumor necrosis factor (TNF); ulcerative colitis (UC)

Year:  2020        PMID: 32940190     DOI: 10.2174/1871530320666200917112802

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  2 in total

Review 1.  Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers.

Authors:  Aldona Kasprzak; Agnieszka Adamek
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

2.  Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-β1 axis.

Authors:  Yin-Peng Li; Xian-Rong Du; Ru Zhang; Qiu Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.